Is dimethyl fumarate (Tecfidera) covered by medical insurance?

Dimethyl fumarate (Tecfidera) is an oral drug used to treat multiple sclerosis (Multiple Sclerosis, MS ). Multiple sclerosis is a chronic disease of the central nervous system characterized by an immune system attack on the myelin sheath of nerve fibers, resulting in impaired nerve impulse conduction, resulting in a variety of neurological symptoms.

The original drug of dimethyl fumarate has been launched in China and has been included in medical insurance. Patients can buy it domestically at a price of about 5,000 to 6,000 yuan. Please consult the local hospital pharmacy for specific prices. The main foreign drug is dimethyl fumarate original drug. The cheaper one is the Indian original drug, which costs more than 2,000 yuan and has the same composition and efficacy as the domestic original drug.

Tecfidera contains dimethyl fumarate, which reduces the symptoms of multiple sclerosis by regulating the activity of the immune system. Dimethyl fumarate is metabolized in the body into an active metabolite that has immunosuppressive effects and helps reduce inflammation and slow the progression of the disease.

Tecfidera is unique in that it is an oral medication, providing multiple sclerosis patients with a convenient treatment option compared to injections or intravenous infusions.

Clinical studies have shown that Tecfidera has significant results in reducing the symptoms of multiple sclerosis, reducing the frequency of attacks and slowing the progression of the disease. However, the use of Tecfidera may be associated with some potential side effects, including digestive discomfort and increased risk of infection, so you should seek medical advice before use.

Overall,Tecfideraprovides patients with multiple sclerosis an innovative treatment option that has the potential to improve patients' quality of life and slow the progression of the disease by modulating the activity of the immune system.